Physician profile
Asif Shah
NPI 1669418786
$7,898.96
in general payments reported to CMS, 2019-2025
32 companies · $1,996 in 2025
The $1,996 reported for 2025 was more than what 93% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $966 · 2020: $1,572 · 2021: $1,273 · 2022: $999 · 2023: $463 · 2024: $632 · 2025: $1,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,530 · Travel and Lodging: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,529.58 |
| Travel and Lodging | $560.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,952.38 | 2019-2025 | Actishield, Prophecy, Bio4 |
| Horizon Therapeutics Plc | $1,177.34 | 2019-2023 | Krystexxa |
| Convatec INC. | $927.26 | 2025 | |
| Tactile Systems Technology INC | $801.21 | 2019-2022 | |
| Integra Lifesciences Corporation | $524.89 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Linvatec Corporation | $455.65 | 2019-2025 | Hercules Suture Anchor System, Biobrace 23mm, Colink 2 |
| Kerecis Limited | $256.30 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Misonix INC | $221.92 | 2019-2021 | |
| Fortis Surgical, LLC | $195.58 | 2023-2025 | |
| Organogenesis INC. | $173.70 | 2020 | |
| Bioventus LLC | $145.03 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $137.18 | 2022-2025 | Nuzyra |
| Wright Medical Technology, INC. | $118.98 | 2020 | |
| Smith+Nephew, INC. | $114.72 | 2019-2025 | Grafix, Oasis |
| Access Pro Medical, LLC | $107.17 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $88.66 | 2020-2022 | |
| Nabriva Therapeutics, Plc | $80.17 | 2021-2022 | |
| Amgen INC. | $73.93 | 2024-2025 | Krystexxa |
| Abbvie INC. | $52.64 | 2022-2023 | Dalvance |
| Vertex Pharmaceuticals Incorporated | $42.05 | 2025 | |
| Spr Therapeutics, INC | $30.63 | 2025 | Sprint Pns System |
| Medtronic, INC. | $29.90 | 2025 | Intellis Adaptivestim |
| Trice Medical, INC. | $29.88 | 2021 | |
| Reprise Biomedical, INC. | $27.94 | 2024-2025 | Miro3d |
| Heron Therapeutics, INC. | $22.90 | 2021 | |
| Fidia Pharma USA INC. | $21.54 | 2019 | |
| Depuy Synthes Sales INC. | $21.48 | 2022 | |
| Paragon 28, INC. | $17.25 | 2021 | |
| Kci USA, INC. | $16.71 | 2019 | |
| Urgo Medical North America, LLC | $14.52 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Axogen | $14.36 | 2025 | |
| Grt US Holding, INC. | $5.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asif Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.